Skip to main content
Top
Published in: Tumor Biology 10/2016

01-10-2016 | Original Article

Oral pathogens change proliferation properties of oral tumor cells by affecting gene expression of human defensins

Authors: T. Hoppe, D. Kraus, N. Novak, R. Probstmeier, M. Frentzen, M. Wenghoefer, S. Jepsen, J. Winter

Published in: Tumor Biology | Issue 10/2016

Login to get access

Abstract

The impact of oral pathogens onto the generation and variability of oral tumors has only recently been investigated. To get further insights, oral cancer cells were treated with pathogens and additionally, as a result of this bacterial cellular infection, with human defensins, which are as anti-microbial peptide members of the innate immune system. After cell stimulation, proliferation behavior, expression analysis of oncogenic relevant defensin genes, and effects on EGFR signaling were investigated. The expression of oncogenic relevant anti-microbial peptides was analyzed with real-time PCR and immunohistochemistry. Cell culture experiments were performed to examine cellular impacts caused by stimulation, i.e., altered gene expression, proliferation rate, and EGF receptor-dependent signaling. Incubation of oral tumor cells with an oral pathogen (Porphyromonas gingivalis) and human α-defensins led to an increase in cell proliferation. In contrast, another oral bacterium used, Aggregatibacter actinomycetemcomitans, enhanced cell death. The bacteria and anti-microbial peptides exhibited diverse effects on the transcript levels of oncogenic relevant defensin genes and epidermal growth factor receptor signaling. These two oral pathogens exhibited opposite primary effects on the proliferation behavior of oral tumor cells. Nevertheless, both microbe species led to similar secondary impacts on the proliferation rate by modifying expression levels of oncogenic relevant α-defensin genes. In this respect, oral pathogens exerted multiplying effects on tumor cell proliferation. Additionally, human defensins were shown to differently influence epidermal growth factor receptor signaling, supporting the hypothesis that these anti-microbial peptides serve as ligands of EGFR, thus modifying the proliferation behavior of oral tumor cells.
Literature
1.
go back to reference Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell. 2006;124:823–35.CrossRefPubMed Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell. 2006;124:823–35.CrossRefPubMed
2.
go back to reference Porta C, Larghi P, Rimoldi M, Totaro MG, Allavena P, Mantovani A, Sica A. Cellular and molecular pathways linking inflammation and cancer. Immunobiology. 2009;214:761–77.CrossRefPubMed Porta C, Larghi P, Rimoldi M, Totaro MG, Allavena P, Mantovani A, Sica A. Cellular and molecular pathways linking inflammation and cancer. Immunobiology. 2009;214:761–77.CrossRefPubMed
3.
go back to reference Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13:759–71.CrossRefPubMed Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13:759–71.CrossRefPubMed
4.
5.
go back to reference Teles RP, Haffajee AD, Socransky SS. Microbiological goals of periodontal therapy. Periodontol. 2006;42:180–218.CrossRef Teles RP, Haffajee AD, Socransky SS. Microbiological goals of periodontal therapy. Periodontol. 2006;42:180–218.CrossRef
6.
go back to reference Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol. 2011;38(Suppl. 11):60–84.CrossRefPubMed Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol. 2011;38(Suppl. 11):60–84.CrossRefPubMed
7.
go back to reference Eke PI, Dye BA, Wei L, Slade GD, Thornton-Evans GO, Borgnakke WS, Taylor GW, Page RC, Beck JD, Genco RJ. Update on prevalence of periodontitis in adults in the United States: NHANES 2009-2012. J Periodontol. 2015;17:1–18. Eke PI, Dye BA, Wei L, Slade GD, Thornton-Evans GO, Borgnakke WS, Taylor GW, Page RC, Beck JD, Genco RJ. Update on prevalence of periodontitis in adults in the United States: NHANES 2009-2012. J Periodontol. 2015;17:1–18.
8.
go back to reference Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 2010;8:481–90.CrossRefPubMed Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 2010;8:481–90.CrossRefPubMed
9.
go back to reference Güncü GN, Yilmaz DK, Könönen E, Gürsoy UK. Salivary antimicrobial peptides in early detection of periodontitis. Front Cell Infect Microbiol. 2015;5:99.CrossRefPubMedPubMedCentral Güncü GN, Yilmaz DK, Könönen E, Gürsoy UK. Salivary antimicrobial peptides in early detection of periodontitis. Front Cell Infect Microbiol. 2015;5:99.CrossRefPubMedPubMedCentral
10.
14.
go back to reference Donald CD, Sun CQ, Lim SD, Macoska J, Cohen C, Amin MB, Young AN, Ganz TA, Marshall FF, Petros JA. Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Lab Investig. 2003;83:501–5.CrossRefPubMed Donald CD, Sun CQ, Lim SD, Macoska J, Cohen C, Amin MB, Young AN, Ganz TA, Marshall FF, Petros JA. Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Lab Investig. 2003;83:501–5.CrossRefPubMed
15.
go back to reference Sun CQ, Arnold R, Fernandez-Golarz C, Parrish AB, Almekinder T, He J, Ho SM, Svoboda P, Pohl J, Marshall FF, Petros JA. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res. 2006;66:8542–9.CrossRefPubMed Sun CQ, Arnold R, Fernandez-Golarz C, Parrish AB, Almekinder T, He J, Ho SM, Svoboda P, Pohl J, Marshall FF, Petros JA. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res. 2006;66:8542–9.CrossRefPubMed
16.
go back to reference Wenghoefer M, Pantelis A, Dommisch H, Reich R, Martini M, Allam JP, Novak N, Bergé S, Jepsen S, Winter J. Decreased gene expression of human β-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg. 2008;37:660–3.CrossRefPubMed Wenghoefer M, Pantelis A, Dommisch H, Reich R, Martini M, Allam JP, Novak N, Bergé S, Jepsen S, Winter J. Decreased gene expression of human β-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg. 2008;37:660–3.CrossRefPubMed
17.
go back to reference Winter J, Pantelis A, Reich R, Martini M, Kraus D, Jepsen S, Allam JP, Novak N, Wenghoefer M. Human beta-defensin-1, -2, and -3 exhibit opposite effects on oral squamous cell carcinoma cell proliferation. Cancer Investig. 2011;29(3):196–201.CrossRef Winter J, Pantelis A, Reich R, Martini M, Kraus D, Jepsen S, Allam JP, Novak N, Wenghoefer M. Human beta-defensin-1, -2, and -3 exhibit opposite effects on oral squamous cell carcinoma cell proliferation. Cancer Investig. 2011;29(3):196–201.CrossRef
18.
go back to reference Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, Hashimoto K, Nagaoka I, Okumura K, Ogawa H. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol. 2007;127(3):594–604.CrossRefPubMed Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, Hashimoto K, Nagaoka I, Okumura K, Ogawa H. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol. 2007;127(3):594–604.CrossRefPubMed
19.
go back to reference Wenghoefer M, Pantelis A, Najafi T, Deschner J, Allam JP, Novak N, Reich R, Martini M, Bergé S, Fischer HP, Jepsen S, Winter J. Gene expression of oncogenes, antimicrobial peptides, and cytokines in the development of oral leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:351–6.CrossRefPubMed Wenghoefer M, Pantelis A, Najafi T, Deschner J, Allam JP, Novak N, Reich R, Martini M, Bergé S, Fischer HP, Jepsen S, Winter J. Gene expression of oncogenes, antimicrobial peptides, and cytokines in the development of oral leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:351–6.CrossRefPubMed
20.
go back to reference Winter J, Pantelis A, Kraus D, Reckenbeil J, Reich R, Jepsen S, Fischer HP, Allam JP, Novak N, Wenghoefer M. Human alpha-defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours. BMC Cancer. 2012;12(1):465.CrossRefPubMedPubMedCentral Winter J, Pantelis A, Kraus D, Reckenbeil J, Reich R, Jepsen S, Fischer HP, Allam JP, Novak N, Wenghoefer M. Human alpha-defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours. BMC Cancer. 2012;12(1):465.CrossRefPubMedPubMedCentral
21.
go back to reference M.Y. Radeva, F. Jahns, A. Wilhelm, M. Glei, U. Settmacher, K.O. Greulich, et al. Defensins alpha 6 (DEFA 6) overexpression threshold of over 60 fold can distinguish between adenoma and fully blown colon carcinoma in individual patients. BMC Cancer. 2010;10. doi:10.1186/1471-2407-10-588. M.Y. Radeva, F. Jahns, A. Wilhelm, M. Glei, U. Settmacher, K.O. Greulich, et al. Defensins alpha 6 (DEFA 6) overexpression threshold of over 60 fold can distinguish between adenoma and fully blown colon carcinoma in individual patients. BMC Cancer. 2010;10. doi:10.​1186/​1471-2407-10-588.
22.
go back to reference Kraus D, Deschner J, Jäger A, Wenghoefer M, Bayer S, Jepsen S, Allam JP, Novak N, Meyer R, Winter J. Human β-defensins differently affect proliferation, differentiation, and mineralization of osteoblast-like MG63 cells. J Cell Physiol. 2012;227(3):994–1003. doi:10.1002/jcp.22808.CrossRefPubMed Kraus D, Deschner J, Jäger A, Wenghoefer M, Bayer S, Jepsen S, Allam JP, Novak N, Meyer R, Winter J. Human β-defensins differently affect proliferation, differentiation, and mineralization of osteoblast-like MG63 cells. J Cell Physiol. 2012;227(3):994–1003. doi:10.​1002/​jcp.​22808.CrossRefPubMed
23.
go back to reference Winter J, Pantelis A, Reich R, Jepsen S, Allam JP, Novak N, Wenghoefer M. Risk estimation for a malignant transformation of oral lesions by S100 A7 and doc-1 gene expression. Cancer Investig. 2011;29:478–84.CrossRef Winter J, Pantelis A, Reich R, Jepsen S, Allam JP, Novak N, Wenghoefer M. Risk estimation for a malignant transformation of oral lesions by S100 A7 and doc-1 gene expression. Cancer Investig. 2011;29:478–84.CrossRef
25.
go back to reference Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611–22.CrossRefPubMed Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611–22.CrossRefPubMed
26.
go back to reference D. Kraus, J. Reckenbeil, M. Wenghoefer, H. Stark, M. Frentzen, J.P. Allam, et al. Ghrelin promotes oral tumor cell proliferation by modifying GLUT1 expression. Cell Mol Life Sci. 2016. D. Kraus, J. Reckenbeil, M. Wenghoefer, H. Stark, M. Frentzen, J.P. Allam, et al. Ghrelin promotes oral tumor cell proliferation by modifying GLUT1 expression. Cell Mol Life Sci. 2016.
27.
go back to reference Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76–85.CrossRefPubMed Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76–85.CrossRefPubMed
28.
go back to reference Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.CrossRefPubMed Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.CrossRefPubMed
29.
go back to reference Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1971;227:680–5.CrossRef Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1971;227:680–5.CrossRef
30.
go back to reference Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology. 1992;24:145–9.PubMed Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology. 1992;24:145–9.PubMed
31.
go back to reference Wenghoefer M, Pantelis A, Dommisch H, Götz W, Reich R, Bergé S, Martini M, Allam JP, Jepsen S, Merkelbach-Bruse S, Fischer HP, Novak N, Winter J. Nuclear hBD-1 accumulation in malignant salivary gland tumours. BMC Cancer. 2008;8:290.CrossRefPubMedPubMedCentral Wenghoefer M, Pantelis A, Dommisch H, Götz W, Reich R, Bergé S, Martini M, Allam JP, Jepsen S, Merkelbach-Bruse S, Fischer HP, Novak N, Winter J. Nuclear hBD-1 accumulation in malignant salivary gland tumours. BMC Cancer. 2008;8:290.CrossRefPubMedPubMedCentral
32.
go back to reference Pantelis A, Wenghoefer M, Haas S, Merkelbach-Bruse S, Pantelis D, Jepsen S, Bootz F, Winter J. Down regulation and nuclear localization of human β-defensin-1 in pleomorphic adenomas of salivary glands. Oral Oncol. 2009;45:526–30.CrossRefPubMed Pantelis A, Wenghoefer M, Haas S, Merkelbach-Bruse S, Pantelis D, Jepsen S, Bootz F, Winter J. Down regulation and nuclear localization of human β-defensin-1 in pleomorphic adenomas of salivary glands. Oral Oncol. 2009;45:526–30.CrossRefPubMed
33.
go back to reference Joly S, Compton LM, Pujol C, Kurago ZB, Guthmiller JM. Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Oral Microbiol Immunol. 2009;24:353–60.CrossRefPubMed Joly S, Compton LM, Pujol C, Kurago ZB, Guthmiller JM. Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Oral Microbiol Immunol. 2009;24:353–60.CrossRefPubMed
34.
go back to reference Kesting MR, Loeffelbein DJ, Hasler RJ, Wolff KD, Rittig A, Schulte M, Hirsch T, Wagenpfeil S, Jacobsen F, Steinstraesser L. Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. Cancer Investig. 2009;27:575–81.CrossRef Kesting MR, Loeffelbein DJ, Hasler RJ, Wolff KD, Rittig A, Schulte M, Hirsch T, Wagenpfeil S, Jacobsen F, Steinstraesser L. Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. Cancer Investig. 2009;27:575–81.CrossRef
35.
go back to reference Bick RJ, Poindexter BJ, Buja LM, Lawyer CH, Milner SM, Bhat S. Nuclear lokalization of hBD-1 in human keratinocytes. J Burn Wounds. 2007;7:25–32. Bick RJ, Poindexter BJ, Buja LM, Lawyer CH, Milner SM, Bhat S. Nuclear lokalization of hBD-1 in human keratinocytes. J Burn Wounds. 2007;7:25–32.
36.
go back to reference Winter J, Pantelis A, Allam JP, Novak N, Reich R, Martini M, Bergé S, Deschner J, Jepsen S, Wenghoefer M. High α-defensin and S100 A7 expression and missing DOC-1 down-regulation characterize irritation fibromas of the oral cavity and may counteract malignant transformation. J Craniofac Surg. 2011;22:100–4.CrossRefPubMed Winter J, Pantelis A, Allam JP, Novak N, Reich R, Martini M, Bergé S, Deschner J, Jepsen S, Wenghoefer M. High α-defensin and S100 A7 expression and missing DOC-1 down-regulation characterize irritation fibromas of the oral cavity and may counteract malignant transformation. J Craniofac Surg. 2011;22:100–4.CrossRefPubMed
37.
go back to reference Nakhjiri SF, Park Y, Yilmaz Ö, Chung WO, Watanabe K, El-Sabaeny A, Park K, Lamont RJ. Inhibition of epithelial cell apoptosis by Porphyromonas gingivalis. FEMS Microbiol Lett. 2001;200:145–9.CrossRefPubMed Nakhjiri SF, Park Y, Yilmaz Ö, Chung WO, Watanabe K, El-Sabaeny A, Park K, Lamont RJ. Inhibition of epithelial cell apoptosis by Porphyromonas gingivalis. FEMS Microbiol Lett. 2001;200:145–9.CrossRefPubMed
38.
go back to reference Shimada T, Sugano N, Nishihara R, Suzuki K, Tanaka H, Ito K. Differential effects of five Aggregatibacter actinomycetemcomitans strains on gingival epithelial cells. Oral Microbiol Immunol. 2008;23:455–8.CrossRefPubMed Shimada T, Sugano N, Nishihara R, Suzuki K, Tanaka H, Ito K. Differential effects of five Aggregatibacter actinomycetemcomitans strains on gingival epithelial cells. Oral Microbiol Immunol. 2008;23:455–8.CrossRefPubMed
39.
go back to reference Kuboniwa M, Hasegawa Y, Mao S, Shizukuishi S, Amano A, Lamont RJ, Yilmaz Ö. P. Gingivalis accelerated gingival epithelial cell progression through the cell cycle. Microbes Infect. 2009;10:122–8.CrossRef Kuboniwa M, Hasegawa Y, Mao S, Shizukuishi S, Amano A, Lamont RJ, Yilmaz Ö. P. Gingivalis accelerated gingival epithelial cell progression through the cell cycle. Microbes Infect. 2009;10:122–8.CrossRef
40.
go back to reference Kraus D, Winter J, Jepsen S, Jäger A, Meyer R, Deschner J. Interactions of adiponectin and lipopolysaccharide from Porphyromonas gingivalis on human oral epithelial cells. PLoS One. 2012;7(2):e30716.CrossRefPubMedPubMedCentral Kraus D, Winter J, Jepsen S, Jäger A, Meyer R, Deschner J. Interactions of adiponectin and lipopolysaccharide from Porphyromonas gingivalis on human oral epithelial cells. PLoS One. 2012;7(2):e30716.CrossRefPubMedPubMedCentral
41.
go back to reference Gallimidi AB, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein AM, Nussbaum G, Elkin M. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015;6:22613–23.CrossRefPubMedCentral Gallimidi AB, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein AM, Nussbaum G, Elkin M. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015;6:22613–23.CrossRefPubMedCentral
42.
go back to reference Mas JM, Aloy P, Marti-Renom MA, Oliva B, de Llorens R, Avilés FX, Querol E. Classification of protein disulphide-bridge topologies. J Comp Aided Mol Des. 2001;15:477–87.CrossRef Mas JM, Aloy P, Marti-Renom MA, Oliva B, de Llorens R, Avilés FX, Querol E. Classification of protein disulphide-bridge topologies. J Comp Aided Mol Des. 2001;15:477–87.CrossRef
43.
go back to reference Benitez BAS, Komives EA. Disulfide bond plasticity in epidermal growth factor. Proteins. 2000;40:168–74.CrossRef Benitez BAS, Komives EA. Disulfide bond plasticity in epidermal growth factor. Proteins. 2000;40:168–74.CrossRef
44.
go back to reference Kim D, Dai J, Fai LY, Yao H, Son YO, Wang L, Prathesshkumar P, Kondo K, Shi X, Zhang Z. Constitutive activation of epidermal growth factor receptor promotes tumorigenesis of Cr (VI)-transformed cells through decreased reactive oxygen species and apoptosis resistance development. J Biol Chem. 2015;290(4):2213–24. doi:10.1074/jbc.M114.619783.CrossRefPubMed Kim D, Dai J, Fai LY, Yao H, Son YO, Wang L, Prathesshkumar P, Kondo K, Shi X, Zhang Z. Constitutive activation of epidermal growth factor receptor promotes tumorigenesis of Cr (VI)-transformed cells through decreased reactive oxygen species and apoptosis resistance development. J Biol Chem. 2015;290(4):2213–24. doi:10.​1074/​jbc.​M114.​619783.CrossRefPubMed
Metadata
Title
Oral pathogens change proliferation properties of oral tumor cells by affecting gene expression of human defensins
Authors
T. Hoppe
D. Kraus
N. Novak
R. Probstmeier
M. Frentzen
M. Wenghoefer
S. Jepsen
J. Winter
Publication date
01-10-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 10/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-016-5281-x

Other articles of this Issue 10/2016

Tumor Biology 10/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine